SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shasun Pharmaceuticals informs about Outcome of Board Meeting

08 Jun 2015 Evaluate

Shasun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on June 08, 2015, has approved the conversion of 7,100,000 convertible warrants into equity shares of the Company, which were issued on May 30, 2014 to Sequent Scientific Limited, Mumbai, on preferential basis at a price of Rs 110 per share including premium of Rs 108 per share.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1876.00
Dr. Reddys Lab 1286.45
Cipla 1307.25
Zydus Lifesciences 944.60
Lupin 2270.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×